![Jonathan Hopper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Hopper
Hoofd Techniek/Wetenschap/O&O bij
VERICEL CORPORATION
Vermogen: 3 M $ op 31-07-2026
Profiel
Jonathan Mark Hopper is currently Chief Medical Officer at Vericel Corp.
since 2018.
Formerly, Dr. Hopper was Vice President-Global Medical Director at Stryker Corp.
from 2010 to 2014, Medical Director at Ferring Pharmaceuticals, Inc. from 2017 to 2018, Chief Medical Officer at Osiris Therapeutics, Inc. from 2014 to 2016, Senior Medical Officer at the United Kingdom Department of Health & Social Care, and Vice President-Medical Affairs at Convatec, Inc. from 2006 to 2010.
Education includes an MBA from Keele University in 2003 and an undergraduate degree from the University of Birmingham Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERICEL CORPORATION 0,15% | 26-06-2026 | 75.753 ( 0,15% ) | 3 M $ | 31-07-2026 |
Actieve functies van Jonathan Hopper
| Bedrijven | Functie | Begin |
|---|---|---|
| VERICEL CORPORATION | Hoofd Techniek/Wetenschap/O&O | 20-08-2018 |
Eerdere bekende functies van Jonathan Hopper
| Bedrijven | Functie | Einde |
|---|---|---|
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
| OSIRIS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 12-04-2016 |
| STRYKER CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-11-2014 |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Hoofd Techniek/Wetenschap/O&O | 01-08-2010 |
United Kingdom Department of Health & Social Care
 United Kingdom Department of Health & Social Care General GovernmentGovernment Functions as a health and social care department | Corporate Officer/Principal | - |
Opleiding van Jonathan Hopper
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
74
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Stryker Corp.
 Stryker Corp. Medical SpecialtiesHealth Technology Manufactures and markets reconstructive, medical and surgical, and neurotechnology and spine products | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
United Kingdom Department of Health & Social Care
United Kingdom Department of Health & Social Care General GovernmentGovernment Functions as a health and social care department | Government |
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
Keele University
 Keele University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Birmingham Medical School
 University of Birmingham Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
